Deal snapshot: Gemini Therapeutics to Merge with Rare Blood Disorder Specialist Disc Medicine.

MANews-(C)2009-2022

US-based precision medicine company Gemini Therapeutics, Inc. (NASDAQ: GMTX) and US-based biopharmaceutical company Disc Medicine, Inc have entered into a definitive merger agreement to combine the companies in an all-stock transaction, the companies said.

The combined company will focus on advancing Disc's...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT